Sino Biopharmaceutical Partners with Boehringer Ingelheim to Bring Innovative Cancer Therapies to China
Sino Biopharmaceutical Ltd (HKG: 1177) has announced a strategic partnership with Germany’s Boehringer Ingelheim (BI)...
Deals
Zhejiang Dian Diagnostics Partners with Hangzhou Medical College to Establish Education Base
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a prominent player in the medical diagnostics space,...
Applied Protein Technology Secures Series C Financing to Accelerate Multi-Omics Innovation
Shanghai-based Applied Protein Technology (APTBIO), a pioneer in life science technology services driven by mass...
Siemens Healthineers and Siemens China Partner with Fudan Hospital Logistic Service on Green Imaging Centers
Germany-based Siemens Healthineers AG, along with its subsidiary Siemens China, has entered into a strategic...
Eisai Forges Strategic Partnership with China Resource Medicine and China Resources Sanjiu for Pharmaceutical Collaboration
Japanese pharmaceutical company Eisai (TYO: 4523) has entered into a cooperation agreement with China Resource...
Genmab Acquires Profound Bio for $1.8 Billion, Targeting Expanding ADC Pipeline
Denmark-based biotech Genmab A/S (NASDAQ: GMAB) has announced a significant all-cash acquisition of Sino-US biotech...
Gilead Extends Collaboration with Nurix Therapeutics for Targeted Protein Degradation by Two Years
Gilead Sciences (NASDAQ: GILD) has announced a two-year extension of its 2019 collaboration with Nurix...
RemeGen Plans RMB 2.55 Billion Private Placement to Fund Innovative Drug Development
China-based RemeGen (HKG: 9995) has announced plans to raise RMB 2.55 billion (approximately USD 280.5...
Legend Biotech and Janssen Pharmaceutical Expand Partnership with Novartis for Carvykti Production
Legend Biotech Corporation (NASDAQ: LEGN), a leading Chinese biotech firm, and its U.S. partner Janssen...
China Medical System Expands Portfolio with Incyte’s Povorcitinib for Autoimmune Diseases
China Medical System Holdings (CMS; HKG: 0867) has announced a new cooperation and licensing agreement...
ETERN Therapeutics Secures Funding to Advance LLPS Platform and Clinical Trials for Anti-Tumor Drugs
ETERN Therapeutics, a Shanghai-based developer of small-molecule anti-tumor drugs, has announced the commencement of a...
Shanghai Unveils Massive Investment Projects and Funds to Boost High-Tech Industries
Shanghai has unleashed a flurry of policy-backed project signings and initiatives, marking a significant boost...
Beijing’s Changping District and State-owned Capital Firm Launch RMB 20 Billion Healthcare Fund
The Changping district of Beijing municipality has reached an agreement with Beijing State-owned Capital Operation...
Gilead Strikes Deal with Xilio Therapeutics for Tumor-Activated IL-12 Candidate
Gilead Sciences (NASDAQ: GILD) has announced an in-licensing agreement with fellow US biotechnology company Xilio...
BeiGene and GenFleet Join Forces for DLBCL Trial Combining Brukinsa and GFH009
BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a China-based biotechnology company, has entered into...
Shanghai Medicilon Forms Strategic Partnerships with Binhui Biopharmaceutical and Innoforce Pharmaceuticals
Shanghai Medicilon Biomedical Co., Ltd (SHA: 688202), a prominent Chinese biotech firm, has entered into...
BeiGene Terminates Partnership with Shoreline Therapeutics for NK Cell Therapies
A close examination of BeiGene’s (NASDAQ: BGNE; HKG: 6160; SHA: 688235) recent annual report has...
Recbio and Rongsheng Biotech Join Forces to Develop New Adjuvant Vaccine Technologies
Jiangsu Recbio Technology Co., Ltd (HKG: 2179) and Shanghai Rongsheng Biotech Co., Ltd have announced...
Merck Expands Global Footprint with Largest M Lab Collaboration Center in Shanghai
Merck KGaA (ETR: MRK), a leading German technology company, has announced the completion of the...
Kangtai Biological Partners with AstraZeneca and Beijing Daxing District to Boost Vaccine Market Presence
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601), a prominent biopharmaceutical company based in China,...